Brahmer JR, Lee JS, Ciuleanu TE, Caro RB, et al. Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer in CheckMate 227. J Clin Oncol 2022 Oct 12:101200JCO2201503. doi: 10.1200/JCO.22.01503.
PMID: 36223558